These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32671305)

  • 1. A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology.
    Berkenstock M; Patel S; Ackert J
    J Curr Ophthalmol; 2020; 32(2):195-198. PubMed ID: 32671305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
    Laguno M; Murillas J; Blanco JL; Martínez E; Miquel R; Sánchez-Tapias JM; Bargallo X; García-Criado A; de Lazzari E; Larrousse M; León A; Loncá M; Milinkovic A; Gatell JM; Mallolas J
    AIDS; 2004 Sep; 18(13):F27-36. PubMed ID: 15316335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients.
    Macías J; Rivero A; Cifuentes C; Camacho A; Neukam K; Rivero-Juárez A; Mira JA; Torre-Cisneros J; Gómez-Mateos J; Pineda JA
    Enferm Infecc Microbiol Clin; 2013; 31(7):424-9. PubMed ID: 23453582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response of US veterans to treatment for the hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    Hepatology; 2007 Jul; 46(1):37-47. PubMed ID: 17567830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy.
    Aboushady M; Alwassief A; Abdelrazik M; Ziada D; Shahba H; Elmestikawy A; Elbahrawy A
    J Interferon Cytokine Res; 2019 Sep; 39(9):539-546. PubMed ID: 31173550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.
    Younossi ZM; McCullough AC; Barnes DS; Post A; Ong JP; O'Shea R; Martin LM; Bringman D; Farmer D; Levinthal G; Mullen KD; Carey WD; Tavill AS; Ferguson R; Gramlich T
    Dig Dis Sci; 2005 May; 50(5):970-5. PubMed ID: 15906777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.
    El Raziky M; Zayed NA; Abdel Baki A; Mansour SA; Shahin RMH
    J Med Virol; 2017 Oct; 89(10):1823-1829. PubMed ID: 28480960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report].
    Crochet M; Ingster-Moati I; Even G; Dupuy P
    J Fr Ophtalmol; 2004 Mar; 27(3):257-62. PubMed ID: 15039627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.
    Horsmans Y; Colle I; Van Vlierberghe H; Langlet P; Adler M; Bourgeois N; Brenard R; Michielsen P; Goossens A; Bruckers L;
    Acta Gastroenterol Belg; 2008; 71(3):293-7. PubMed ID: 19198574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1.
    Sievert W; Dore GJ; McCaughan GW; Yoshihara M; Crawford DH; Cheng W; Weltman M; Rawlinson W; Rizkalla B; Depamphilis JK; Roberts SK;
    Hepatology; 2011 Apr; 53(4):1109-17. PubMed ID: 21480317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
    Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b.
    Mach TH; Cieśla A; Warunek W; Janas-Skulina U; Cibor D; Owczarek D; Ciećko-Michalska I
    Pol Arch Med Wewn; 2011 Dec; 121(12):434-9. PubMed ID: 22157768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy].
    Ke YC; Li LH; Hu FY; He Y; Lan Y; Chen XJ; Tang XP; Cai WP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):181-5. PubMed ID: 27095760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin induced anaemia: the effect of vitamin D supplementation on erythropoietin and erythrocyte indices in normal Wistar rat.
    Refaat B; Ashour TH; El-Shemi AG
    Int J Clin Exp Med; 2014; 7(9):2667-76. PubMed ID: 25356124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.
    Rivero-Juárez A; Mira JA; Pérez-Camacho I; Macías J; Camacho A; Neukam K; Torre-Cisneros J; Merchante N; Pineda JA; Rivero A;
    J Antimicrob Chemother; 2011 Jun; 66(6):1351-3. PubMed ID: 21415037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
    Kim ET; Kim LH; Lee JI; Chin HS
    Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia caused by ribavirin and interferon treatment.
    Skabelund AJ; Hauser TR; Goist KJ
    Clin J Gastroenterol; 2011 Oct; 4(5):313-317. PubMed ID: 26189631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin.
    Reau N; Hadziyannis SJ; Messinger D; Fried MW; Jensen DM
    Am J Gastroenterol; 2008 Aug; 103(8):1981-8. PubMed ID: 18796095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy.
    Kashif M; Saleem MK; Farooka IK; Husnain A; Siddiqui AM
    Pak J Med Sci; 2015; 31(1):174-7. PubMed ID: 25878638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.